使用非甾体抗雄激素治疗前列腺癌的基本原理。

The Prostate. Supplement Pub Date : 1992-01-01 DOI:10.1002/pros.2990210513

R C Benson

{"title":"使用非甾体抗雄激素治疗前列腺癌的基本原理。","authors":"R C Benson","doi":"10.1002/pros.2990210513","DOIUrl":null,"url":null,"abstract":"Flutamide is a non-steroidal anti-androgen which has been used to treat prostate cancer. Results to date indicate that flutamide is as effective as other conventional therapy. It has only moderate activity in patients in whom conventional hormonal therapy has previously failed, but appears to be beneficial when combined with an LHRH agonist.","PeriodicalId":77436,"journal":{"name":"The Prostate. Supplement","volume":"4 ","pages":"85-90"},"PeriodicalIF":0.0000,"publicationDate":"1992-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/pros.2990210513","citationCount":"6","resultStr":"{\"title\":\"A rationale for the use of non-steroidal anti-androgens in the management of prostate cancer.\",\"authors\":\"R C Benson\",\"doi\":\"10.1002/pros.2990210513\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Flutamide is a non-steroidal anti-androgen which has been used to treat prostate cancer. Results to date indicate that flutamide is as effective as other conventional therapy. It has only moderate activity in patients in whom conventional hormonal therapy has previously failed, but appears to be beneficial when combined with an LHRH agonist.\",\"PeriodicalId\":77436,\"journal\":{\"name\":\"The Prostate. Supplement\",\"volume\":\"4 \",\"pages\":\"85-90\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1992-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1002/pros.2990210513\",\"citationCount\":\"6\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Prostate. Supplement\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1002/pros.2990210513\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Prostate. Supplement","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/pros.2990210513","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 6

摘要

氟他胺是一种非甾体抗雄激素，已被用于治疗前列腺癌。迄今为止的结果表明氟他胺与其他常规疗法一样有效。它在传统激素治疗失败的患者中仅具有中等活性，但与LHRH激动剂联合使用时似乎是有益的。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

A rationale for the use of non-steroidal anti-androgens in the management of prostate cancer.

Flutamide is a non-steroidal anti-androgen which has been used to treat prostate cancer. Results to date indicate that flutamide is as effective as other conventional therapy. It has only moderate activity in patients in whom conventional hormonal therapy has previously failed, but appears to be beneficial when combined with an LHRH agonist.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

The Prostate. Supplement

自引率

0.00%

发文量